If a practice chooses to sell, it must provide documentation to HPS for profile creation. Once completed, the profile will be anonymously listed on the HPS platform, and offers will appear on the doctor's dashboard, the same dashboard used to track testing activity and valuation growth from the addition of VSD into the practice.
The hypothesis is that ancillary-based EBITDA is more attractive to buyers than provider-dependent EBITDA.
Provider-dependent EBITDA is often diluted due to inflation and high staffing costs. Moreover, it can significantly decline once a provider exits a practice. Conversely, ancillary-based EBITDA requires minimal overhead and remains stable even after a provider's departure, ensuring long-term revenue continuity.
HPS's platform includes over 1,400 buyers interested in acquiring healthcare practices. Many of these buyers prefer the ancillary EBITDA model and are willing to pay a premium for practices demonstrating strong ancillary revenue streams.
By integrating VSD, medical professionals can enhance patient outcomes, increase practice valuation, and unlock financial and policy engagement opportunities—all while receiving seamless support from Medical Synergy, VSD, and HPS.